Tag:
hepatitis B drug
News
The FDA has approved a new hepatitis B drug that offers patients a chance to end long-term treatment.
The U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen), a hepatitis B drug developed by the British pharmaceutical company GSK. The new...